Last reviewed · How we verify
helium:oxygen mixture
helium:oxygen mixture is a Small molecule drug developed by Baqiyatallah Medical Sciences University. It is currently FDA-approved.
At a glance
| Generic name | helium:oxygen mixture |
|---|---|
| Sponsor | Baqiyatallah Medical Sciences University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- HELIox CardiOPlegia Trial During Cardiac surgERy (NA)
- Helium:Oxygen Noninvasive Positive Pressure Ventilation in Patients Exposed to Sulfur Mustard (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- helium:oxygen mixture CI brief — competitive landscape report
- helium:oxygen mixture updates RSS · CI watch RSS
- Baqiyatallah Medical Sciences University portfolio CI
Frequently asked questions about helium:oxygen mixture
What is helium:oxygen mixture?
helium:oxygen mixture is a Small molecule drug developed by Baqiyatallah Medical Sciences University.
Who makes helium:oxygen mixture?
helium:oxygen mixture is developed and marketed by Baqiyatallah Medical Sciences University (see full Baqiyatallah Medical Sciences University pipeline at /company/baqiyatallah-medical-sciences-university).
What development phase is helium:oxygen mixture in?
helium:oxygen mixture is FDA-approved (marketed).
Related
- Manufacturer: Baqiyatallah Medical Sciences University — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing